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Previously, Knight and colleagues reported a patient with
schizophrenia (SCZ) who carried the complex chromosomal
rearrangement inv(7)(p12.3;q21.11), t(7;8)(p12.3;p23). The
translocation between chromosomes 7 and 8 resulted in a
disruption of ABCA13, suggesting a possible role for this
gene in the etiology of SCZ. This gene is member 13 of the
ATP-binding cassette transporter subfamily A. Protein
expression analyses in the adult mouse showed Abca13
expression in the brain (Knight et al., 2009).
Subsequent resequencing of functional domain exons
identified rare variants that were associated with both
SCZ and bipolar disorder (BPD; Knight et al., 2009).
Furthermore, the same research group screened an SCZ
and BPD sample for the presence of small copy number
variants (CNVs) in this gene. Multiplex amplicon
quantification assays were performed on DNA samples
from 1004 patients with SCZ, on 428 patients with BPD,
and on 1086 controls, and no over-representation of CNVs
among patients compared with controls was identified
(Pickard et al., 2012).
We sought to elucidate further the potential role of CNVs in
ABCA13 and analyzed three clinically well-characterized
data sets for the occurrence of CNVs in ABCA13: (i) 575
patients with major depressive disorder (MDD; Degenhardt
et al., 2012), (ii) 882 patients with BPD (Priebe et al., 2012),
and (iii) 1637 patients with SCZ or schizoaffective disorder.
Of them, 487 patients with SCZ have previously been
included in a GWA study by Rietschel et al. (2011). In
addition, 1618 controls (described in detail in Degenhardt
et al., 2012) were screened for the presence of CNVs in
ABCA13. All participants were of German descent according
to self-reported ancestry, and each participant provided
written informed consent before inclusion.
All individuals were genotyped on HumanHap550v3,
Human610-Quadv1, and Human660W-Quad arrays
(Illumina, San Diego, California, USA). Detailed informa-
tion on CNV detection and CNV quality control is
provided elsewhere (Degenhardt et al., 2012). Only those
markers common to all three chips were analyzed.
Participants were excluded if their SD from the log R
ratio calculated over all SNPs exceeded 0.30.
The three data sets were analyzed for the presence of
both microdeletions and microduplications including the
ABCA13 gene plus 10 kb upstream and downstream of the
Refseq gene boundary (chr7: 48208389–48657637; hg18).
All CNVs were required to span a minimum of 10
consecutive SNPs and have a log Bayes Factor (Quanti-
SNP) or confidence value (PennCNV) of at least 10.
No CNV including ABCA13 was identified in our three
patient samples, nor in the controls. Hence, we did not
find any evidence for CNVs in ABCA13 as a risk factor for
the development of SCZ, BPD, or MDD. It cannot be
excluded, however, that extremely rare CNVs might play
a role in disease development, which would only be
detectable in considerably larger samples. It is therefore
important to gather data from several large studies before
final conclusions regarding the involvement of CNVs in
ABCA13 in SCZ, BPD, or MDD can be drawn.
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